Alcoholic liver disease (ALD) is characterized by
lipid accumulation and liver injury. However, how chronic alcohol consumption causes hepatic
lipid accumulation remains elusive. The present study demonstrates that activation of the
mechanistic target of rapamycin complex 1 (
mTORC1) plays a causal role in alcoholic steatosis,
inflammation, and liver injury. Chronic-plus-binge
ethanol feeding led to hyperactivation of
mTORC1, as evidenced by increased phosphorylation of mTOR and its downstream
kinase S6 kinase 1 (S6K1) in hepatocytes. Aberrant activation of
mTORC1 was likely attributed to the defects of the
DEP domain-containing mTOR-interacting
protein (DEPTOR) and the
nicotinamide adenine dinucleotide-dependent deacetylase
sirtuin 1 (
SIRT1) in the liver of chronic-plus-binge
ethanol-fed mice and in the liver of patients with ALD. Conversely, adenoviral overexpression of hepatic DEPTOR suppressed
mTORC1 signaling and ameliorated alcoholic hepatosteatosis,
inflammation, and acute-on-chronic liver injury. Mechanistically, the
lipid-lowering effect of hepatic DEPTOR was attributable to decreased proteolytic processing, nuclear translocation, and transcriptional activity of the lipogenic
transcription factor sterol regulatory
element-binding protein-1 (SREBP-1). DEPTOR-dependent inhibition of
mTORC1 also attenuated alcohol-induced cytoplasmic accumulation of the lipogenic regulator
lipin 1 and prevented alcohol-mediated inhibition of
fatty acid oxidation. Pharmacological intervention with
rapamycin alleviated the ability of alcohol to up-regulate lipogenesis, to down-regulate
fatty acid oxidation, and to induce steatogenic phenotypes. Chronic-plus-binge
ethanol feeding led to activation of SREBP-1 and
lipin 1 through S6K1-dependent and independent mechanisms. Furthermore, hepatocyte-specific deletion of
SIRT1 disrupted DEPTOR function, enhanced
mTORC1 activity, and exacerbated
alcoholic fatty liver,
inflammation, and liver injury in mice.
CONCLUSION: